Ionis Pharmaceuticals (IONS) Total Liabilities (2009 - 2026)
Ionis Pharmaceuticals (IONS) posted quarterly Total Liabilities of $2.6 billion for Q2 2026, up 8.56% year-over-year from $2.4 billion in Q2 2025, and down 13.65% quarter-over-quarter from $3.0 billion in Q1 2026.
Ionis Pharmaceuticals (IONS) Total Liabilities (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Total Liabilities history runs 18 years deep, the most recent figure standing at $2.6 billion for Q2 2026.
- In Q2 2026, Total Liabilities rose 8.56% year-over-year to $2.6 billion; the TTM figure through Jun 2026 stood at $2.6 billion (up 8.56% YoY), while the FY2025 annual figure was $3.0 billion, up 25.65% from the prior year.
- Total Liabilities for Q2 2026 stood at $2.6 billion, down from $3.0 billion in the prior quarter.
- The five-year high for Total Liabilities was $3.0 billion in Q4 2025, with the low at $1.8 billion in Q1 2022.
- The 5-year median for Total Liabilities is $2.4 billion (2024), against an average of $2.4 billion.
- The sharpest annual moves came in 2023 and 2024: Total Liabilities soared 43.28% in 2023, then slipped 7.63% in 2024.
- Ionis Pharmaceuticals' Total Liabilities stood at $2.0 billion in 2022, then jumped by 32.76% to $2.6 billion in 2023, then fell by 7.22% to $2.4 billion in 2024, then grew by 25.65% to $3.0 billion in 2025, then slipped by 15.82% to $2.6 billion in 2026.
- Business Quant data shows IONS's Total Liabilities at $2.6 billion in Q2 2026, $3.0 billion in Q1 2026, and $3.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Ionis Pharmaceuticals | 9.48 Bn | 7.43 Bn | 265.21 Mn | 2.55 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.55 Bn |
| Mar 31, 2026 | 2.96 Bn |
| Dec 31, 2025 | 3.03 Bn |
| Sep 30, 2025 | 2.42 Bn |
| Jun 30, 2025 | 2.35 Bn |
| Mar 31, 2025 | 2.34 Bn |
| Dec 31, 2024 | 2.42 Bn |
| Sep 30, 2024 | 2.42 Bn |
| Jun 30, 2024 | 2.43 Bn |
| Mar 31, 2024 | 2.47 Bn |
| Dec 31, 2023 | 2.60 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.54 Bn |
| Mar 31, 2023 | 2.40 Bn |
| Dec 31, 2022 | 1.96 Bn |
| Sep 30, 2022 | 1.83 Bn |
| Jun 30, 2022 | 1.83 Bn |
| Mar 31, 2022 | 1.81 Bn |
| Dec 31, 2021 | 1.84 Bn |
| Sep 30, 2021 | 1.88 Bn |